Patent · US Active

Phenylimidazole compounds

US8329739B2 · kind B2 · utility

3Cited by
1References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 3, 2010
Grant dateDec 11, 2012
Priority date—
Expiry dateFeb 3, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D409/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

[Object] To provide a pharmaceutical product (chemotherapeutic agent) effective in the prevention and treatment of hyperlipidemia, obesity, etc.[Solving Means] A phenylimidazole compound represented by the following General Formula (1):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.